Markets:

Overview

News

Currencies

International

Treasuries

Tvardi Therapeutics, Inc. - Common Stock (NQ:TVRD)

2.020 +0.070 (+3.59%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tvardi Therapeutics, Inc. - Common Stock

The trading volume of these stocks is deviating from the norm in today's session. ↗

June 30, 2026

Via Chartmill

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 31, 2025

Via Chartmill

Unusual volume stocks in Monday's session ↗

October 20, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

October 16, 2025

Unusual volume stocks are being observed in Thursday's session.

Via Chartmill

Unusual volume stocks in Wednesday's session ↗

October 15, 2025

Which stocks have an unusual volume on Wednesday?

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 14, 2025

Via Benzinga

Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks ↗

October 13, 2025

Tvardi Therapeutics stock falls as Phase 2 IPF trial of TTI-101 shows no significant FVC improvement, with high variability and placebo response.

Via Benzinga

Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge ↗

October 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 13, 2025

Via Benzinga

Dow Surges 1%; Fastenal Shares Fall After Q3 Results ↗

October 13, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 13, 2025

Via Benzinga

Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today? ↗

October 13, 2025

The company said that its investigational drug did not meet its goal in a study, and no statistically significant differences between placebo and treatment arms were observed after preliminary review...

Via Stocktwits

Tvardi Posts Q2 Net Income Turnaround ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside ↗

June 12, 2025

Tvardi advances fibrosis drug TTI-101 in IPF and liver cancer as Piper initiates with $78 target; merger boosts cash runway into late 2026.

Via Benzinga

This Modine Manufacturing Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 25, 2025

Via Benzinga

Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗

April 25, 2025

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.